Trimel to Participate in the 38th Annual Deutsche Bank Healthcare Conference
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 05/28/13 -- Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that management is scheduled to present an overview of the Company at the 38th annual Deutsche Bank Health Care Conference at the Westin Boston Waterfront Hotel on May 30th, 2013 at 4:10 p.m. (Eastern time). The presentation materials will also be made available on the Trimel website at .
For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or Trimel via email at .
About Trimel
Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. A New Drug Application for CompleoTRT™, a product utilizing Trimel's licensed bioadhesive intranasal gel technology, has been filed with the FDA for regulatory approval in the United States. For more information, please visit .
Contacts:
Trimel Pharmaceuticals Corporation
Kenneth Howling
Chief Financial Officer
(416) 679-0536
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.05.2013 - 17:00 Uhr
Sprache: Deutsch
News-ID 264005
Anzahl Zeichen: 3773
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 184 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Trimel to Participate in the 38th Annual Deutsche Bank Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Trimel Pharmaceuticals Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
